Abstract
Purpose. Atherosclerosis is the underlying factor leading to such cardiovascular diseases (CVD) as stroke, aneurysm, and myocardial infarction. The early detection of atherosclerotic plaques is considered to be crucial for successful prevention and/or therapeutic and dietary intervention of CVD. Current diagnostic practice, on the other hand, can only detect the problem at an advanced stage. The purpose of this study was to examine the potential of using a radiolabeled cholesterol ester analog/acetylated low density lipoprotein (AcLDL) conjugate as a diagnostic agent for the early and non-invasive detection of atherosclerosis and for the monitoring of the effects of drug therapy.
Methods. Cholesteryl iopanoate (CI), a cholesterylester analog, was synthesized, radiolabeled, and incorporated into AcLDL. Early atherosclerotic lesions were induced in New Zealand White rabbits. 125I-C1/ AcLDL was injected intravenously at 2 μCi/kg. Blood samples were taken at different time intervals after injection and clearance of the injected drug from blood was studied. The rabbits were sacrificed after 72 hours and the distribution of radioactivity in various organs was investigated. Aortae of both atherosclerotic lesion and control rabbits were removed for Sudan IV staining and autoradiography in order to confirm the formation of the atherosclerotic lesion and localization of radioactivity.
Results. The injected drug was found to be cleared from blood following a two compartment model. Radioactivity in the atherosclerotic aorta was found to be about 8 times higher than that in normal aorta, suggesting that the proposed diagnostic probe was selectively taken up by the atherosclerotic lesion. The autoradiography and staining confirmed that the localization of the proposed probe was superimposed with the atherosclerotic lesion site.
Conclusions. The results suggested that incorporation of CI into AcLDL resulted in the selective localization of CI at the atherosclerotic plaque areas. CI/AcLDL labeled with appropriate radioisotope has the potential to be used as a probe for visualization of early atherosclerotic lesion using scintigraphy technology.
Similar content being viewed by others
REFERENCES
C. J. Schwartz, A. J. Valente, E. A. Sprague, J. L. Kelley, and R. M. Nerem. The pathogenesis of atherosclerosis, an overview. Clin. Cardiol. 14:I-1-I-16 (1991).
E. N. Arnett, M. Isner, D. R. Redwood, K. M. Kent, W. P. Daker, H. Ackerstien, and W. C. Roberts. Coronary artery narrowing in coronary heart disease: Comparison of cineangiographic and necropsy findings. Ann. Int. Med. 91:350-356 (1979).
Z. Vlodaver, R. Frech, R. A. Van Tassel, and J. E. Edwards. Correlation of the antimortem coronary arteriogram and the postmortem specimen. Circulation 47:162-169 (1973).
R. G. Gerrity. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103:181-190 (1981).
L. M. Buja, T. Kita, J. L. Goldstein, Y. Watanabe and M. S. Brown. Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia. Arteriosclerosis 3:87-101 (1983)
J. L. Goldstein, Y. K. Ho, S. K. Basu and M. S. Brown. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:333-337 (1979).
S. Yla-Herttuala, M. E. Rosenfeld, S. Parthasarathy, E. Sigal, T. Sarkioja, J. L. Witztum, and D. Steinberg. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 87:1146-1152 (1991).
M. A. Longino, J. P. Weichert, S. W. Schwendner, S. M. Szabo, R. E. Counsell, and G. M. Glazer. Biodistribution of a new lipid-soluble CT contrast agent. Evaluation of cholesteryl iopanoate in the rabbit. Invest. Radiol. 18:275-278 (1983).
V. N. Schumaker and D. L. Puppione. Sequential flotation ultracentrifugation. Methods in Enzymology 128:155-171 (1986).
M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248 (1976).
S. K. Basu, J. L. Goldstein, R. G. W. Anderson, and M. S. Brown. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemic fibroblasts. Proc. Natl. Acad. Sci. USA 73:3178-3182 (1976).
R. H. Seevers, M. P. Groziak, J. P. Weichert, S. W. Schwendner, S. M. Szabo, M. A. Longino, and R. E. Counsell. Potential tumor-or organ-imaging agents. 23 Sterol esters of iopanoic acid. J. Med. Chem. 25:1500-1503 (1982).
J. P. Weichert, M. A. Longino, D. A. Bakan, M. G. Spigarelli, T-S Chou, S. W. Schwendner, and R. E. Counsell. Polyiodinated triglyceride analogs as potential computed tomography imaging agents for the liver. J. Med. Chem. 38:636-646 (1995).
M. R. DeGalan, S. W. Schwendner, R. W. S. Skinner, M. A. Longino, M. Gross, and R. E. Counsell. Iodine-125 cholesteryl iopanoate for measuring extent of atherosclerosis in rabbits. J. Nucl. Med. 29:503-508 (1988).
A. D. Cardin, C. A. Price, N. Hirose, M. A. Krivanek, D. T. Blankenship, J. Chao, and S. J. T. Mao. Structural organization of apolipoprotein B-100 of human plasma low density lipoproteins. Comparison to B-48 of chylomicrons and very low density lipoproteins. J. Biol. Chem. 261:16,744-16,748 (1986).
M. Samadi-Baboli, G. Favre, P. Canal, and G. Soula. Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice. Br. J. Cancer 68:319-326 (1993).
H. Sinzinger, H. Bergmann, J. Kaliman, and P. Angelberger. Imaging of human atherosclerotic lesions using 123I-low density lipoprotein. Eur. J. Nucl. Med. 12:291-292 (1986).
H. Sinzinger and P. Angelberger. Imaging and kinetic studies with radiolabeled autologous low-density-lipoproteins (LDL) in human atherosclerosis. Nucl. Med. Comm. 9:859-866 (1988).
A. B. Roberts, A. M. Lees, R. S. Lees, H. W. Strauss, J. T. Fallon, J. Taveras, and S. Kopiwoda. Selective accumulation of low density lipoproteins in damaged arterial wall. J. Lipid Res. 24:1160-1167 (1983).
J. M. Rosen, S. P. Butler, G. E. Meinken, T. S. T. Wang, R. Ramakrishan, S. C. Srivastava, P. O. Alderson, and H. N. Ginsberg. Indium-111 labeled LDL: A potential agent for imaging atherosclerotic disease and lipoprotein distribution. J. Nucl. Med. 31:343-350 (1990).
J. M. Nicolas, B. Leclef, H. Jardez, A. Keyeux, J. A. Melin, and A. Trouet. Imaging atherosclerotic lesions with 111In-labeled low density lipoprotein. (abstract) Vienna. Proceedings of the International Atherosclerosis Congress. p A219 (1989).
R. S. Lees, H. D. Garabedian, A. M. Lees, D. J. Schumacher, A. Miller, J. L. Isaacsohn, A. Derksen, and H. W. Strauss. Technetium-99m low density lipoprotein: Preparation and biodistribution. J. Nucl. Med. 26:1056-1062 (1985).
A. M. Lees, R. S. Lees, F. J. Schoen, J. L. Issacsohn, A. J. Fischman, K. A. McKusick, and H. W. Strauss. Imaging human atherosclerosis with99mTc-labeled low density lipoprotein. Atherosclerosis 8:461-470 (1988).
D. E. Atsma, R. I. J. Feitsma, J. Camps, F. M. van't Hooft, E. E. van der Wall, W. Nieuwenhuizen, and E. K. J. Pauwels. Potential of99mTc-LDLs labeled by two different methods for scintigraphic detection of experimental atherosclerosis in rabbits. Arteriosclerosis Thrombosis 13:78-83 (1993).
I. Kenji, K. Toru, K. Noriaki, N. Yutaka, and K. Chuichi. Uptake of acetylated LDL by peritoneal macrophages obtained from normal and Watanabe heritable hyperlipidemic rabbits, an animal model for familial hypercholesterolemia. Biochim. Biophys. Acta. 962:387-389 (1988).
M. S. Brown and J. L. Goldstein. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Review Biochem. 52:223-261 (1983).
J. Narula, A. Petrov, K. Y. Pak, C. Ditlow, F. Chen, and B. A. Khaw. Noninvasive detection of atherosclerotic lesions by99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells. Chest 111:1684-1690 (1997).
B. A. Allison, M. T. Crespo, A. K. Jain, A. M. Richter, Y. N. Hsiang, and J. G. Levy. Delivery of benzoporphyrin derivative, a photosensitizer, into atherosclerotic plaque of Watanabe heritable hyperlipidemic rabbits and balloon-injured New Zealand rabbits. Photochem. Photobiol. 65:877-883 (1997).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xiao, W., Wang, L., Scott, T. et al. Radiolabeled Cholesteryl lopanoate/ Acetylated Low Density Lipoprotein as a Potential Probe for Visualization of Early Atherosclerotic Lesions in Rabbits. Pharm Res 16, 420–426 (1999). https://doi.org/10.1023/A:1018881904228
Issue Date:
DOI: https://doi.org/10.1023/A:1018881904228